These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9306390)

  • 21. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

  • 22. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
    Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
    Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIH tightens up monitoring of gene-therapy mishaps.
    Smaglik P
    Nature; 2000 Mar; 404(6773):5. PubMed ID: 10716412
    [No Abstract]   [Full Text] [Related]  

  • 24. US authorities uphold suspension of SCID gene therapy.
    Fox JL
    Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene therapy. RAC's advice: proceed with caution.
    Kaiser J
    Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
    [No Abstract]   [Full Text] [Related]  

  • 26. Changing roles for academia and industry in genetics and gene therapy.
    Friedmann T
    Mol Ther; 2000 Jan; 1(1):9-11. PubMed ID: 10933906
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical research. Gene therapy a suspect in leukemia-like disease.
    Marshall E
    Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
    [No Abstract]   [Full Text] [Related]  

  • 28. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
    Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
    Zufferey R; Nagy D; Mandel RJ; Naldini L; Trono D
    Nat Biotechnol; 1997 Sep; 15(9):871-5. PubMed ID: 9306402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo.
    Kobinger GP; Weiner DJ; Yu QC; Wilson JM
    Nat Biotechnol; 2001 Mar; 19(3):225-30. PubMed ID: 11231554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experts attempt to redefine principles for treating HIV.
    Fox JL
    Nat Biotechnol; 1997 Jan; 15(1):14-5. PubMed ID: 9035096
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
    Smaglik P
    Nature; 1999 Dec; 402(6763):707. PubMed ID: 10617181
    [No Abstract]   [Full Text] [Related]  

  • 35. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy on trial.
    Marshall E
    Science; 2000 May; 288(5468):951-7. PubMed ID: 10841710
    [No Abstract]   [Full Text] [Related]  

  • 37. Oncology's first Phase 0 trial.
    Rowan K
    J Natl Cancer Inst; 2009 Jul; 101(14):978-9. PubMed ID: 19584322
    [No Abstract]   [Full Text] [Related]  

  • 38. Competitors try collaboration to speed drug development.
    Patlak M
    J Natl Cancer Inst; 2010 Jun; 102(12):841-3. PubMed ID: 20530762
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of HVJ envelope vector and its application to gene therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoring public trust in gene therapy.
    Kennedy EM
    J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.